OLIVIERI, JACOPO
 Distribuzione geografica
Continente #
NA - Nord America 748
EU - Europa 466
AS - Asia 178
AF - Africa 35
OC - Oceania 2
Totale 1.429
Nazione #
US - Stati Uniti d'America 746
IT - Italia 136
UA - Ucraina 76
CN - Cina 64
FR - Francia 59
SE - Svezia 49
SG - Singapore 45
IE - Irlanda 44
DE - Germania 32
TR - Turchia 28
DK - Danimarca 27
CI - Costa d'Avorio 19
HK - Hong Kong 17
MA - Marocco 16
FI - Finlandia 15
GB - Regno Unito 15
KR - Corea 13
IN - India 6
BE - Belgio 4
PL - Polonia 4
AU - Australia 2
CA - Canada 2
CH - Svizzera 2
NL - Olanda 2
TH - Thailandia 2
VN - Vietnam 2
IR - Iran 1
RU - Federazione Russa 1
Totale 1.429
Città #
Chandler 127
Jacksonville 81
Ashburn 50
Fairfield 48
Boardman 46
Dublin 44
Centro 39
New York 39
Wilmington 34
Seattle 27
Woodbridge 26
Houston 24
Singapore 24
Ann Arbor 20
Cambridge 20
Abidjan 19
Lawrence 18
Princeton 18
Beijing 17
Hong Kong 17
San Mateo 16
Des Moines 14
Redmond 14
Turin 11
San Diego 10
Guangzhou 7
Ancona 6
Cagliari 6
Porto 6
Leawood 5
Marche 5
Pune 5
Rome 5
Bologna 4
Bristol 4
Los Angeles 4
Fayetteville 3
Milan 3
Shenzhen 3
Washington 3
Bangkok 2
Brussels 2
Cremona 2
Florence 2
Frankfurt am Main 2
London 2
Malo 2
Palermo 2
Parma 2
Prescot 2
Shanghai 2
Sydney 2
Wuhan 2
Zurich 2
Bubbiano 1
Bushey 1
Cedar Knolls 1
Charlotte 1
Chiaravalle 1
Chicago 1
Chiswick 1
Chizhou 1
Dong Ket 1
Ganzhou 1
Hanover 1
Helsinki 1
Inzago 1
Izmir 1
Jinan 1
Jinhua 1
Modena 1
Montecassiano 1
Montesilvano 1
Nanjing 1
New Bedfont 1
New Delhi 1
Newark 1
Ningbo 1
Ottawa 1
Paris 1
Qingdao 1
Quanzhou 1
Redwood City 1
Sabz 1
Toronto 1
Udine 1
Wuhu 1
Wuxi 1
Yiwu 1
Totale 935
Nome #
A Comparison of the Conditioning Regimens BEAM and FEAM for Autologous Hematopoietic Stem Cell Transplantation in Lymphoma: An Observational Study on 1038 Patients From Fondazione Italiana Linfomi 108
Predicting failure of hematopoietic stem cell mobilization before it starts: The predicted poor mobilizer (pPM) score 102
null 100
The Exaggerated Collagen Expression in Gvhd-Fibroblasts Is Effectively Inhibited By Therapeutic Concentration of Nilotinib 93
Long lasting biological effects of PDGFR agonistic auto-antibodies in scleroderma 92
In vitro comparison of different TKI activity in T-Cell populations: selective sparing of Treg by Nilotinib. 91
Reversal of poor graft function with iron-chelating therapy after allogeneic transplantation for severe aplastic anemia 88
Meccanismi del danno cellulare da chemioterapici su cellule normali e neoplastiche 88
A Combination of Lenalidomide and Rituximab (ReRi) As Salvage Therapy in Elderly Patients Affected By Diffuse Large B Cells (DLBCL) Lymphoma Relapsed and Refractory 86
Tailored Therapy in an Unselected Population of 91 Elderly Patients with DLBCL Prospectively Evaluated Using a Simplified CGA. 82
Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHD 81
A new method to assess the viability of collected CD34+ cells before reinfusion: a prospective study in 50 autotransplanted patients. 80
Tirosin kinase inhibitors in chronic graft versus host disease: from bench to bedside. 77
Preventive Effects of Cardotoxicities By Liposomal Anthracyclines non Pegilated in 95 Perspective Patients Affected By Lymphoma and Monitored By Biomarkers and Ecocardiography 77
Modern management of anthracycline-induced cardiotoxicity in lymphoma patients: Low occurrence of cardiotoxicity with comprehensive assessment and tailored substitution by nonpegylated liposomal doxorubicin 77
Consensus recommendations for improvement of unmet clinical needs-the example of chronic graft-versus-host disease: A systematic review and meta-analysis 73
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors: A Registry-Based Study of the Italian Blood and Marrow Transplantation Society (GITMO) 40
null 20
Nilotinib in steroid-refractory cGVHD: prospective parallel evaluation of response, according to NIH criteria and exploratory response criteria (GITMO criteria) 13
A novel method to evaluate prethawing viability of cryopreserved CD34+ hematopoietic stem cells for autologous transplantation. 7
Totale 1.475
Categoria #
all - tutte 7.873
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.873


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020105 0 0 0 0 0 0 19 12 23 4 10 37
2020/2021276 21 31 39 3 29 5 24 22 29 22 27 24
2021/2022157 6 29 1 2 1 9 16 8 8 20 26 31
2022/2023329 24 48 19 22 27 48 1 25 67 2 39 7
2023/2024210 27 2 13 26 21 59 3 14 2 6 5 32
2024/2025153 51 38 7 2 14 20 21 0 0 0 0 0
Totale 1.475